Q2 2025 Beauty Health Co Earnings Call Transcript
Key Points
- The Beauty Health Co (SKIN) exceeded both revenue and adjusted EBITDA guidance for the third consecutive quarter.
- Significant gross margin improvement was reported, with GAAP at 62.8% and adjusted at 65.9%.
- The company successfully launched the HydraFillic with Pep9 booster, which quickly became a top-performing product.
- The consumables business, now over 70% of revenue, remains strong, demonstrating the impact of the razor-razor blade model.
- Operating expenses were reduced by nearly 18%, and the company closed the quarter with $212 million in cash following strategic debt restructuring.
- Device sales remain pressured due to macroeconomic headwinds.
- There was a 36.5% year-over-year decline in global device revenue.
- Revenue in the Americas was down 9.8%, and APAC revenue declined 43.4%, partly due to the transition to a distributor model in China.
- Churn was higher than expected, affecting the installed base growth.
- The company is projecting $4 million in tariff-related expenses for the remainder of the year.
Good day, and welcome to The Beauty Health Company second-quarter 2025 earnings conference call. (Operator Instructions) Please note, this event is being recorded. I would now like to turn the conference over to Norberto Aja, Investor Relations. Please go ahead.
Thank you, operator, and good afternoon. Thank you for joining The Beauty Health Company's 2025 Second Quarter Conference Call. Our earnings press release was issued this afternoon and is available on our Investor Relations site at beautyhealth.com. Joining me on the call today is BeautyHealth's Chief Executive Officer, Marla Beck; along with our Chief Financial Officer, Michael Monahan. Before we begin, please note that, today's discussion includes forward-looking statements, including guidance and underlying assumptions, which are subject to risks and uncertainties.
Actual results may differ materially. For a further discussion of risks related to our business, please refer to our SEC filings. We may also reference non-GAAP measures
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
